Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,857
Closed -$457K 377
2026
Q1
$457K Buy
4,857
+1,972
+68% +$197K 0.31% 115
2025
Q4
$285K Buy
+2,885
New +$279K 0.17% 263
2025
Q2
Sell
-3,915
Closed -$237K 556
2025
Q1
$237K Buy
+3,915
New +$273K 0.14% 328
2024
Q2
Sell
-5,645
Closed -$322K 531
2024
Q1
$322K Buy
+5,645
New +$339K 0.18% 227
2023
Q4
Sell
-5,581
Closed -$322K 567
2023
Q3
$322K Buy
5,581
+327
+6% +$20.6K 0.2% 228
2023
Q2
$327K Sell
5,254
-5,823
-53% -$389K 0.22% 196
2023
Q1
$801K Buy
+11,077
New +$867K 0.51% 28
2022
Q4
Sell
-7,441
Closed -$496K 474
2022
Q3
$496K Buy
7,441
+3,488
+88% +$258K 0.32% 94
2022
Q2
$300K Buy
+3,953
New +$300K 0.21% 220

Other funds holding INCY

MQS Management's INCY Position: Q2 2026 in Review

MQS Management sold out of Incyte (INCY) in Q2 2026, closing a stake of 4,857 shares — an estimated $457K sold.

MQS Management first reported a position in INCY in Q2 2022 and held it in 9 quarters. The position peaked at $801K in Q1 2023. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • MQS Management reported no remaining Incyte position as of Q2 2026 after selling out during the quarter.
  • MQS Management sold 4,857 Incyte shares in Q2 2026, an estimated $457K.
  • MQS Management first reported a position in Incyte in Q2 2022 and held it in 9 quarters.
  • MQS Management's Incyte position peaked at $801K in Q1 2023.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.